Global Dosimetry Solutions, Inc., Names Tom Logan as Chief Executive Officer
13 5월 2004 - 9:00PM
PR Newswire (US)
Global Dosimetry Solutions, Inc., Names Tom Logan as Chief
Executive Officer COSTA MESA, Calif., May 13 /PRNewswire/ -- Global
Dosimetry Solutions, Inc. a leading provider of dosimetry services
(analytical determination of exposure to ionizing radiation) has
announced the appointment of Tom Logan as Chief Executive Officer
(CEO). The new appointment was made following the company's
announcement that Sandra (Sandi) Nemecek, the company's president
and a founding employee plans to retire at the end of this year.
Logan joins GDS after having served as its Chief Transition Officer
in conjunction with the purchase of GDS by American Capital
Strategies (NASDAQ:ACAS) from Valeant Pharmaceutical. With more
than 20 years of experience in global manufacturing, Logan has held
senior operating and financial roles within the contract
manufacturing, consumer products and integrated energy industries.
He is the former Chairman of the Board of the Association for
Financial Professionals, and is a current Board member of the New
Piper Aircraft Corporation. Logan holds a bachelor of science
degree and a master's degree in business from Cornell University.
"Global Dosimetry Solutions has a reputation for providing the
highest level of customer service in the industry, and we look
forward to enhancing and extending that reputation in the months
and years ahead," said Logan. "I am delighted to have the
opportunity to work with the finest team in the industry as we
pursue these goals on behalf of our many customers." "Tom brings
tremendous experience in managing high-volume industrial
businesses, has extensive international experience and a great
leadership style, which will serve our customers and employees
well," said Robert Klein, Managing Director of American Capital.
"We look forward to continued growth and exceptional results under
Tom's leadership." About Global Dosimetry Solutions Global
Dosimetry Solutions, based in Costa Mesa, California, is one of the
world's largest providers of radiation dosimetry services. GDS
offers a full range of services for measuring ionizing radiation
primarily through film, thermoluminescent and track etch
technologies. Since early 1970, the company has continually
provided state-of-the-art personal radiation monitoring services to
hospitals, medical and dental offices, university and national
laboratories, nuclear power plants and other industries. GDS
provides services to more than 500,000 people globally. For more
information, please visit: http://www.dosimetry.com/. About
American Capital Strategies, Ltd. American Capital is a publicly
traded buyout and mezzanine fund with capital resources in excess
of $2.7 billion. American Capital is an investor in and sponsor of
management and employee buyouts; invests in private equity
sponsored buyouts, and provides capital directly to private and
small public companies. American Capital provides senior debt,
mezzanine debt and equity to fund growth, acquisitions and
recapitalizations. Companies interested in learning more about
American Capital's flexible financing should contact Mark Opel,
Principal, at (800) 248-9340, or visit their website. DATASOURCE:
Global Dosimetry Solutions, Inc. CONTACT: Monica Golden of True
Parallel, +1-714-273-2776, , for Global Dosimetry Solutions, Inc.
Web site: http://www.dosimetry.com/
Copyright
American Capital Strategies (NASDAQ:ACAS)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
American Capital Strategies (NASDAQ:ACAS)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024